Janus Henderson Group’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
Other funds holding PCSA
SFCM
Janus Henderson Group's PCSA Position: Q3 2026 in Review
Janus Henderson Group opened a new position in Processa Pharmaceuticals (PCSA) in Q3 2026: 18,016 shares worth $29.5M. The stake represents 0.01% of the portfolio and ranks #541 among its holdings.
18 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.
- Janus Henderson Group held 18,016 shares of Processa Pharmaceuticals worth $29.5M as of Q3 2026.
- Processa Pharmaceuticals was a new Janus Henderson Group position in Q3 2026.
- Processa Pharmaceuticals made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #541 holding.
- 18 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.